Earnings Season Overview - The Q2 2025 earnings season has begun, with investment strategist Shay Boloor highlighting five stocks to watch across various sectors, including AI, connectivity, and next-gen infrastructure [1][2] Company Summaries Alphabet (NASDAQ: GOOG) - Alphabet is expected to report Q2 earnings of $2.16 per share and total revenue of approximately $93.6 billion, reflecting revenue growth [1] - In Q1 2025, Alphabet reported EPS of $2.81, beating expectations, with revenue of $90.23 billion, up 12% year-over-year [2] - The company announced a $70 billion share buyback and a 5% dividend hike [2] Robinhood (NASDAQ: HOOD) - Robinhood's stock has surged nearly 150% year-to-date, trading at $98, benefiting from the cryptocurrency boom and new retirement accounts [7][9] - Analysts project Q2 earnings of $0.30 per share and revenue of $882 million, with a focus on user growth and product expansion [9] AST SpaceMobile (NASDAQ: ASTS) - AST SpaceMobile is focused on delivering global satellite broadband directly to mobile phones, with a Q2 EPS loss projected at $0.19 and revenue expected to surge 472% to $5.15 million [10] - The company is working on the BlueWalker 3 satellite and plans for commercial deployment, although it remains a speculative investment [10] Oklo (NYSE: OKLO) - Oklo aims to commercialize compact nuclear reactors for AI data centers, with the stock rallying 156% year-to-date, trading at $56.08 [13] - The company is expected to report a Q2 loss of $0.12 per share, with no revenue as it develops its Aurora Powerhouse reactors [15] Advanced Micro Devices (NASDAQ: AMD) - AMD is projected to report Q2 earnings of $0.50 per share on $7.4 billion in revenue, with growth expected from Data Center and Client segments [16] - In Q1 2025, AMD reported EPS of $0.96, with revenue of $7.44 billion, up 36% year-over-year [17] - The stock has surged over 20% in the past month, trading at $146, with investors watching the impact of AMD's MI300X AI chips [19]

Core Viewpoint - Goldman Sachs maintains a "Neutral" rating on AMD (AMD.US) with a target price of $140, citing impressive returns and revenue but concerns over growth potential due to intense competition in the AI and GPU sectors [1] Financial Performance - AMD's revenue has grown by 21.71% over the past 12 months, reaching $27.75 billion, with a return of 19.28% over the last six months, reflecting strong investor enthusiasm for AI [1] - The company's current P/E ratio stands at 101.36, indicating a historically high valuation [1] Competitive Landscape - AMD faces challenges in the server CPU market as the adoption of ARM-based processors increases, which are favored for their efficiency and scalability [2] - The company’s commercial GPU products are under significant competition from NVIDIA, which benefits from a strong AI software stack and established ecosystem [2] - Increased funding is flowing towards ASICs designed for specific AI tasks, presenting another challenge for AMD [2] Analyst Sentiment - Analysts express uncertainty regarding AMD's AI future, with mixed reports on its prospects. KeyBanc Capital Markets maintains a "Market Perform" rating, projecting $7-8 billion in AI revenue from the MI355 AI GPU by 2025 [3] - Truist Securities holds a "Hold" rating, citing uncertainties in the company's data center GPU strategy and customer acceptance [3] - Mizuho raises its target price to $152, adjusting revenue expectations for the June quarter to $7.4 billion [3] Optimistic Outlook - Melius Research upgrades AMD to a "Buy" rating with a new target price of $211, based on potential EPS of $8 within two years [4] - HSBC also upgrades AMD to "Buy," doubling its target price from $100 to $200, citing the premium pricing of the new MI350 series products [4] - The MI350 chips' compatibility with existing data center infrastructure is seen as an attractive feature [4] Upcoming Financial Disclosure - AMD is set to release its Q2 fiscal year 2025 earnings report on August 5, which is anticipated to provide insights into its AI plans, revenue trajectory, and profitability amid significant R&D investments [5]

Core Insights - NVIDIA Corporation is experiencing significant sales losses due to U.S. export restrictions, particularly from the trade conflict with China, resulting in a $2.5 billion loss in Q1 of fiscal 2026 and an anticipated $8 billion loss in Q2 [1][10] - The company is focusing on sovereign AI projects to mitigate risks associated with the trade war, establishing partnerships and infrastructure in various regions [1][5] Group 1: Sovereign AI Initiatives - Sovereign AI involves countries developing their own AI infrastructure to protect data and maintain control, with NVIDIA playing a crucial role in these efforts [2] - NVIDIA has announced major AI factory projects in Saudi Arabia, planning to deliver 18,000 AI chips, and has received strong support for its initiatives in Europe from leaders in France and Germany [2][3] - The European Union is investing $20 billion to build four AI gigafactories, and NVIDIA is collaborating with firms like Foxconn and local governments in Taiwan and the UAE to enhance AI infrastructure [3] Group 2: Competitive Landscape - Competitors like Advanced Micro Devices (AMD) and Intel are also trying to expand in the AI infrastructure space but are lagging behind NVIDIA in sovereign AI projects [6] - AMD is gaining traction with its Instinct MI300X chips, but lacks a full-stack solution comparable to NVIDIA's offerings [7] - Intel is promoting its Gaudi 3 AI chips as a cost-effective option, but its AI ecosystem is still developing and does not provide a complete package [8] Group 3: Financial Performance and Valuation - NVIDIA's shares have increased by approximately 19.1% year-to-date, outperforming the Zacks Computer and Technology sector, which gained 7% [9] - The company trades at a forward price-to-earnings ratio of 33.13, higher than the sector average of 27.37 [11] - The Zacks Consensus Estimate for NVIDIA's fiscal 2026 and 2027 earnings indicates a year-over-year increase of about 41.8% and 31.9%, respectively, with recent upward revisions for fiscal 2027 estimates [12]

来源：币界网 政策角力场：鸽派联储VS鹰派白宫 币界网报道，降息预期强化：花旗坚持认为美联储将从9月开始降息，并在明年3月前累计降息125个基 点。美联储理事鲍曼与沃勒近期转向支持降息，强化了市场共识。数据支撑：核心PCE持续低于目标， 叠加多位官员态度软化，使5月纪要中"前景不确定性增加"的措辞显得过时。花旗预计本次纪要将调整 为"前景不确定性降低"，为9月行动铺路。关税冲击波：特朗普的关税政策引发供应链重构恐慌。铜关 税威胁导致LME库存暴跌80%，高盛警告市场严重扭曲——美国囤积超40万吨铜(相当于100天消费 量)，而非美地区库存不足10天。通胀隐忧： 克利夫兰联储主席Hammack警告，美联储距通胀目标"还 有距离"，且官方数据可能低估了油价上涨等最新变化。铜、药品关税若落地，恐推升生产成本，削弱 降息空间。 市场韧性之谜：投行为何逆势唱多? 尽管特朗普关税大棒挥舞，华尔街反而集体上调标普500预期，形成鲜明反差。高盛领衔上修：将标普 500年底目标从6100点大幅上调至6600点，隐含5.9%上涨空间，12个月目标看至6900点。美银转向乐 观： 将2025年底目标从5600点上调至6300点，较 ...

作 者丨 LL Insights 编译 | 华尔街大事件 这种新趋势出现的时机，恰逢 AI 加速器供应结构性短缺。由于 HBM 产能紧张，英伟达的订单 排期已到 2026 年之后，云服务商急需一个可靠的备选供应商。AMD 的小芯片（chiplet）策略 使其能以更低的边际硅成本整合更多内存通道，相比单片设计的竞争对手拥有物料成本优势 —— 在 192GB 容量下，每块 GPU 能节省数万美元。当数据中心的电力和空间预算有限时，这种成本 差异在数万个节点的规模下会变得无法忽视。 软件方面的障碍也不再难以逾越。ROCm 6.2 版本新增了原生 vLLM 和 Bits-and-Bytes 支持、 FP8 内核及全新性能分析工具，在训练和推理场景下与 CUDA 的效率差距大幅缩小。Meta 公开 表示，其 Llama 3.1 的生产流量已完全由 MI300X 集群承载，这说明 AMD 的软件栈已经能胜任 最严苛的实时推理工作负载。随着越来越多开源仓库接受 HIP 代码提交，客户的切换成本会逐季 降低。 Instinct MI300X 是首款将 192 GB HBM3e 与 5.3 TB/s 带宽集成于一体的数据中心 ...

Maintain BUY. We are positive on the global potential of Innovent's rich innovative pipelines. Innovent is on track to achieve EBITDA breakeven this year. Backed by smooth development of IBI363, we improved our possibility of success for the asset and raised our DCF-based TP to HK$102.95 from HK$94.74. 机构：招银国际 研究员：Jill WU/Andy WANG IBI363 positioned as a promising next-generation IO therapy with Ph3 trials underway. Strong survival benefits and broad potential position IBI363 (PD-1/IL-2) as a potential bloc ...

Core Viewpoint - The future performance of Nvidia may be significantly impacted by its past performance, with analysts remaining bullish despite high valuation metrics like a price-to-earnings ratio of up to 50 times [4][9]. Revenue Growth and Earnings - Nvidia's revenue is projected to grow from $16.6 billion in 2021 to $130.5 billion by fiscal year 2025, with earnings per share increasing from $0.17 to $2.94 during the same period [6]. - Analysts expect Nvidia's earnings per share to grow by 43% in fiscal year 2026 and by 34% in fiscal year 2027, leading to a projected price-to-earnings ratio of 26.6 by the end of fiscal year 2027 [8]. Market Position and Ecosystem - Over 4 million developers rely on Nvidia's CUDA software platform, which has been in use for 15 years, creating a high switching cost for users [7]. - Nvidia's data center revenue reached $39.1 billion in Q1 2026, a 73% year-over-year increase, despite losing approximately $2.5 billion in revenue due to export restrictions [7]. Competitive Threats - Google poses a significant risk to Nvidia, particularly with its Cloud TPU, which offers a streamlined, one-stop solution for AI model training and inference [11][13]. - Although Google's TPU sales are estimated to be between $6 billion and $9 billion in 2024, this is still a small fraction of Nvidia's projected $115.3 billion data center revenue for fiscal year 2025 [15]. Revenue Concentration and Future Outlook - In Q1 2026, four customers contributed to 54% of Nvidia's total revenue, indicating a high concentration risk [16]. - Nvidia's revenue growth is expected to slow down, with projections indicating a decline to 15% to 20% in the coming years, as the market for training foundational models may saturate [16][18].

作 者丨Bay Area Ideas 编译 | 华尔街大事件 未来业绩最致命的杀手是什么？很可能是过去的业绩。拿英伟达（NASDAQ:NVDA）来说，过去 的表现确实让人惊艳。 当然，这样的表现并不能说明 英伟达今后可能创造的潜在回报。然而，投资者应该意识到，每一 段旅程都会有终点，我们走过的每一米都已远去。 是的，说到"英伟达股票的基本面估值相当高"的说法，分析师坚定地站在英伟达看涨阵营。英伟 达的市盈率可能高达50倍。 尽管出口限制让公司的 H20 芯片损失了约 25 亿美元收入，但这样的增长仍然很惊人。汽车领域 收入 5.7 亿美元，游戏领域 38 亿美元，专业可视化领域 5.1 亿美元 —— 可以说，英伟达差不多 已经是个纯粹的 AI 巨头，就像淘金热里卖铲子的人。 英伟达还没发布 2026 财年的业绩预测，但分析师预计，2026 财年它的每股收益会增长 43%， 2027 财年（截至 2027 年 1 月 1 日）会增长 34%。 | 15.00 | 12.00 | | | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | ...

A c t i o n | 29 Jun 2025 20:44:48 ET │ 13 pages Innovent (1801.HK) R&D Day Takeaways: Leading the Development of Next-Generation IO + ADC CITI'S TAKE During the R&D day, KoLs highlighted promising data of IBI363 in NSCLC, mucosal/acral melanoma and MSS CRC, and its potential to become a cornerstone product for next-generation IO treatment. Innovent is leading the development of next generation of IO+ADC combinations, which could bring broader-spectrum, highly-potent, less-toxic, innovative cancer treatment ...

Accessibility StatementSkip Navigation ADC Platforms Keynote speech R&D Strategy "Over the past decade, Innovent has been at the forefront of China's biopharmaceutical evolution—pioneering the PD-1 immunotherapy era and building China's leading oncology brand, with over 3 million cancer patients treated with our therapies," said Dr. Michael Yu, Founder, Chairman of the Board and CEO of Innovent. "We are entering a new chapter focused on global innovation, powered by a robust pipeline and dual innov ...